Mn Services Vermogensbeheer B.V. Sells 8,100 Shares of CVS Health Co. (NYSE:CVS)

Mn Services Vermogensbeheer B.V. cut its stake in shares of CVS Health Co. (NYSE:CVS) by 1.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 512,200 shares of the pharmacy operator’s stock after selling 8,100 shares during the period. Mn Services Vermogensbeheer B.V.’s holdings in CVS Health were worth $30,251,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Norges Bank bought a new stake in shares of CVS Health in the 4th quarter valued at about $1,092,040,000. Capital International Investors grew its holdings in CVS Health by 47.4% during the fourth quarter. Capital International Investors now owns 33,691,698 shares of the pharmacy operator’s stock valued at $2,660,298,000 after purchasing an additional 10,837,801 shares during the period. Pzena Investment Management LLC increased its stake in CVS Health by 573.8% in the first quarter. Pzena Investment Management LLC now owns 5,553,457 shares of the pharmacy operator’s stock valued at $442,944,000 after purchasing an additional 4,729,207 shares in the last quarter. Capital World Investors raised its holdings in CVS Health by 8.0% in the first quarter. Capital World Investors now owns 43,776,874 shares of the pharmacy operator’s stock worth $3,491,643,000 after purchasing an additional 3,232,172 shares during the period. Finally, Clearbridge Investments LLC boosted its position in shares of CVS Health by 306.6% during the fourth quarter. Clearbridge Investments LLC now owns 3,046,216 shares of the pharmacy operator’s stock worth $240,529,000 after purchasing an additional 2,297,100 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

CVS has been the topic of several research analyst reports. Robert W. Baird assumed coverage on CVS Health in a research note on Thursday, May 30th. They set a “neutral” rating and a $61.00 price objective on the stock. Baird R W upgraded CVS Health to a “hold” rating in a report on Thursday, May 30th. UBS Group lowered CVS Health from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $85.00 to $60.00 in a research report on Thursday, May 2nd. Deutsche Bank Aktiengesellschaft dropped their target price on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Finally, Leerink Partnrs downgraded shares of CVS Health from an “outperform” rating to a “market perform” rating in a research report on Wednesday, May 1st. Eleven analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $73.24.

CVS Health Stock Performance

Shares of CVS Health stock traded up $1.01 during trading on Friday, hitting $58.75. 9,614,381 shares of the stock were exchanged, compared to its average volume of 11,289,169. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78. The company has a fifty day moving average price of $58.86 and a 200-day moving average price of $65.09. The stock has a market capitalization of $73.75 billion, a price-to-earnings ratio of 10.33, a price-to-earnings-growth ratio of 0.57 and a beta of 0.52. CVS Health Co. has a 1-year low of $52.77 and a 1-year high of $83.25.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.73 by $0.10. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The firm had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. During the same quarter in the prior year, the company earned $2.21 earnings per share. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. As a group, equities analysts predict that CVS Health Co. will post 7 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 1st. Stockholders of record on Monday, July 22nd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.53%. The ex-dividend date was Monday, July 22nd. CVS Health’s payout ratio is presently 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.